Aytu Biopharma (AYTU) Operating Income (2016 - 2025)
Historic Operating Income for Aytu Biopharma (AYTU) over the last 17 years, with Q4 2025 value amounting to -$2.0 million.
- Aytu Biopharma's Operating Income fell 1622.42% to -$2.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$8.7 million, marking a year-over-year decrease of 2249.05%. This contributed to the annual value of -$7.8 million for FY2025, which is 25920.15% down from last year.
- Aytu Biopharma's Operating Income amounted to -$2.0 million in Q4 2025, which was down 1622.42% from -$1.5 million recorded in Q3 2025.
- Aytu Biopharma's Operating Income's 5-year high stood at $3.1 million during Q4 2023, with a 5-year trough of -$53.4 million in Q1 2022.
- In the last 5 years, Aytu Biopharma's Operating Income had a median value of -$2.4 million in 2024 and averaged -$9.5 million.
- As far as peak fluctuations go, Aytu Biopharma's Operating Income plummeted by 179289.94% in 2024, and later soared by 25159.67% in 2025.
- Quarter analysis of 5 years shows Aytu Biopharma's Operating Income stood at -$11.3 million in 2021, then soared by 39.19% to -$6.9 million in 2022, then soared by 145.81% to $3.1 million in 2023, then tumbled by 153.88% to -$1.7 million in 2024, then fell by 16.22% to -$2.0 million in 2025.
- Its Operating Income stands at -$2.0 million for Q4 2025, versus -$1.5 million for Q3 2025 and -$7.6 million for Q2 2025.